dr. goy discusses single-agent ibrutinib in mcl
Published 6 years ago • 109 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:09
dr. goy discusses ibrutinib with venetoclax in mcl
-
1:06
dr. goy on efficacy with ibrutinib in mcl
-
1:56
dr. goy discusses long-term follow-up results for ibrutinib in mcl
-
0:53
andre goy, md, discusses the best strategy for using ibrutinib in mcl
-
0:46
dr. goy compares acalabrutinib with ibrutinib in mcl
-
1:20
dr. wang discusses single-agent acalabrutinib in mcl
-
1:00
dr. goy on acalabrutinib versus ibrutinib in mcl
-
2:07
dr. goy discusses intensive therapy for mcl
-
1:25
dr. goy discusses challenges in treatment of mcl
-
1:15
dr. goy on treatment considerations in mcl
-
1:24
dr. goy on preliminary data with ibrutinib/venetoclax in relapsed/refractory mcl
-
0:54
dr. wang on updated data with single-agent acalabrutinib in mcl
-
1:05
dr. goy on combinations with novel agents in relapsed/refractory mcl
-
2:00
dr. goy discusses btk inhibitors in mcl
-
1:06
dr. goy on promising data with acalabrutinib in mcl
-
1:02
dr. goy on the progression of mcl treatment
-
1:13
dr. goy on research efforts with btk inhibitors in mcl
-
1:20
dr. goy the evolution of treatment in relapsed/refractory mcl
-
1:28
dr. goy on the evolution of treatment selection in mcl